Nakhia Impex LLC clinical trials
The registry lists 15 studies whose lead sponsor is Nakhia Impex LLC. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Sep 23, 2026.
Our grouping of 1 registry name, not the registry’s. See them and correct one ↓
- 15studies on the registry
- 0open to participants now
What it is testing
The drugs Nakhia Impex LLC’s studies test, most studies first; none is open now — 1 drug with a page of their own. Each count opens the studies in search.
Studies, none open
- 0 open · 4
All 15 at a glance
Where each study is in its life, its phase and its countries. Each count opens them in search.
- Completed15100%
Over the years
- 20
- 21
- 22
- 23
- 24
- 25
- 926
By the year each study started. 2026 so far in the lighter column.
Registry sponsor names on this page
Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.
Tell us about a missing company
Each name exactly as ClinicalTrials.gov lists it, and how it relates to Nakhia Impex LLC.
- Nakhia Impex LLC15 studiesSame company
Something wrong?
Studies
Recruiting first, then most recently updated. Showing 15 of 15.
- 35 kDa Hyaluronan Fragment (HA35) Reduces Chronic Inflammation of SkinCompletedNCT06387212Not applicable
- Efficacy and Safety of HA35 Gel for Mild Gingival Recession and Periodontal InflammationCompletedNCT07577258Not applicable
- Efficacy and Safety of High-Concentration 35 kDa Hyaluronan Gel for Herpes Zoster-Associated PainCompletedNCT07569978Not applicable
- Efficacy and Safety of High-Dose Oral 35 kDa Hyaluronan for Aesthetic ImprovementCompletedNCT07583108Not applicable
- Efficacy and Safety of Overnight Occlusive HA35 Gel for Facial Aesthetic ImprovementCompletedNCT07584811Not applicable
- Efficacy and Safety of High-Concentration 35 kDa Hyaluronan Gel for Chronic NasopharyngitisCompletedNCT07568548Not applicable
- Extended Therapeutic Effect of 35kDa Hyaluronan Fragment Injection in Patients With Chronic Pain Caused by Myofascial Pain SyndromeCompletedNCT06444035Not applicable
- Efficacy and Safety of HA35 Gel for Ultra-Rapid Skin Pruritus ReliefCompletedNCT07580911Not applicable
- Efficacy and Safety of HA35 Gel for Post-Dental Gingival Pain and SwellingCompletedNCT07584655Not applicable
- Efficacy and Safety of HA35 Gel Nighttime Occlusive Application for TMD PainCompletedNCT07584642Not applicable
- Efficacy of Oral HA35 for Rapid Relief of Oral Pain and Pungent SensationCompletedNCT07630571Not applicable
- 35kDa Hyaluronan Fragment Treatment of Colorectal and Rectal CancerCompletedNCT06209970Not applicable
- Local Injection for the Treatment of Chronic Wounds and Pain Caused by Chronic WoundsCompletedNCT05810649Not applicable
- A Clinical Study of Pain and Discomfort Associated With Advanced Lung CancerCompletedNCT05852002Not applicable
- Freshly Manufactured 35kDa Hyaluronan Fragment HA35 for the Treatment of Chronic WoundsCompletedNCT05764226Not applicable